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A.  Introduction 
The story of evolution is one of heritable variation giving rise, over deep time, to the 
diversity of species that we observe today.  At the time that Darwin put forth his theory nothing 
was known of the molecular phenomena which gave rise to that variation.  However, with the 
structure of DNA solved and the subsequent advances in molecular biology, scientists have 
realized that such variation essential for evolution arises from a delicate balance of both the 
mutation and repair of an organism’s genomic DNA.  In order to understand how this balance 
is achieved, scientists have studied the pathways that bring about the faithful replication of 
genomic DNA as well those which are involved in correcting aberrant DNA modifications.  The 
study of the underlying mechanisms of these pathways has led to the understanding of how 
deficiencies therein can give rise to genome instability, a condition which frequently results in 
tumor development and cancer formation.   
My research is focused on a class of enzymes known as the DNA polymerases, which are 
directly involved in genome stability.  DNA polymerases are instrumental to both the replication 
and maintenance of an organism’s genomic DNA which is subject to numerous lesions such as 
mismatched bases, base loss, base modification, and double stranded breaks [4].  Many of 
these lesions if left unrepaired can stall replication complexes, which can be saved only by 
recruiting one of the recently discovered translesion polymerases [5].  DNA polymerases have 
been classified into six families A, B, C, D, X, and Y based on their phylogenetic relationships 
and they have been shown to participate in a diverse array of pathways in DNA metabolism 
[5]. 
I report here the purification of several DNA polymerases of both the X and Y-family.  Due to 
the highly collaborative nature of modern research, much of the work that I have done has 
been part of a broader collaboration both within our lab and with laboratories in other 
departments or institutions.  Throughout this thesis I report results both from my own research 
experience and from the experience of others.  I have tried to be consistent throughout in 
specifying my unique contribution to the research and in all cases contributions made by 
others are acknowledged. 
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Fig. 1.  Domain structure of full-length hPol λ, 
truncated (β-like) hPol λ, and hPol β 
 
Fig. 2.  Close view of tPolλ•DNA•ddTTP active site [2].  
Residues R386, K422, F506, A510, and R514 are shown 
as sticks surrounding the incoming nucleotide (ddTTP).  
B.  Nucleotide Binding in Human DNA Polymerase λ 
Our interest in DNA polymerase λ began with 
the human genome project, which has revealed 
the existence of at least fifteen different DNA 
polymerases in humans.  Prior to this discovery, 
it was commonly held that relatively few 
enzymes were required for the maintenance and 
replication of an organism’s genome.  Scientists 
have now undertaken the task of elucidating the biological role of these newly discovered DNA 
polymerases.  Pol λ is one such enzyme, and while it shares 54% sequence homology with the 
well-characterized DNA polymerase β (Fig.1) [6, 7] recently acquired genetic and biochemical 
evidence suggests that the biological role of Pol λ is more complex.  Due to its ability to carry 
out gap-filling DNA synthesis, Pol β has been established as the acting polymerase in the 
major pathway to repair single base lesions [8, 9] known as the base excision repair pathway 
(BER).  Because of their sequence homology and shared catalytic activities, it has been 
hypothesized that Pol λ also functions in BER in vivo [10, 11].  Other evidence suggests that 
Pol λ may also participate in V(D)J recombination and non-homologous end joining (NHEJ) 
pathways in vivo [12, 13].  Pol λ, unlike any other characterized DNA polymerase, is unique in 
its ability to bind all nucleotides, correct or incorrect, with high binding affinity [11].  DNA 
polymerases typically bind two ligands: DNA and an incoming nucleotide.  Most DNA 
polymerases, including Pol β, 
discriminate against the incorporation of 
incorrect nucleotides by binding them 
weakly [14].  Data gathered in our lab, 
however, shows that the ground-state 
binding affinity (Kd) of all nucleotides in 
Pol λ is both tight and nonselective [11].  
This phenomenon is of particular 
interest to us because many 
chemotherapeutic agents gain their 
efficacy by mimicking endogenous 
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nucleotides, but of the 30 nucleoside analogues approved by the FDA, none have been 
studied in the context of Pol λ because the enzyme was discovered after their approval.  The 
putative role of Pol λ in DNA repair lends particular significance to Pol λ’s interaction with 
chemotherapeutic agents.  The aim of this project was to establish the structural basis for the 
interactions between Pol λ and incoming nucleotides.  By examining the crystal structure for 
tPol λ in complex with gapped DNA and an incoming nucleotide (Fig. 2), a series of residues 
proposed to interact with the incoming nucleotide were identified.  After carrying out site-
directed mutagenesis on six residues: R386, K422, F506, A510, R514, and R517, we have 
identified three residues, R386, A510, and R514 that play a significant role in high binding 
affinity of incoming nucleotides both correct and incorrect.  Based on the crystal structure of 
the tPol λ ternary complex, we believe that residue R386 interacts with the γ-phosphate of the 
incoming nucleotide by the formation of a salt bridge.  Residue A510 interacts with the base of 
the incoming nucleotide by van der Waal’s interactions.  Residue R514 is positioned at the 
interface between the DNA template and the incoming nucleotide.  As a result, it acts to both 
stabilize the incoming nucleotide and the DNA template.   
Experimental Procedures 
Generation of hPolλ mutants.  All mutants used in this study were generated by Dr. Suo’s 
Biochemistry 521 course (Winter 2005) using site-directed mutagenesis. 
Purification of hPolλ mutants.  The N and C-terminal His6-tagged hPol λ mutant plasmids 
(pET 28b) were transformed into BL21 (DE3) RIL chemical competent cells by heat shock (42° 
C for 45 seconds).  An overnight culture of E. coli expression strain BL21(DE3) RIL carrying 
the mutant plasmid was used to inoculate Luria-Bertani medium containing 40 µg/mL 
kanamycin and 25 µg/mL chloramphenicol, and the cells were grown at 37° C until OD600 = 0.6.  
The cultures were induced with 0.15 mM IPTG and incubated at 19° C for 9 h (OD600 ~1.7).  
Induced cells were harvested (4000 rpm,15 min) and resuspended in Buffer A (10 mM KHPO4, 
pH 7.0, 500 mM NaCl, 10 mM MgCl2, 10% glycerol, 0.1% beta-mercaptoethanol, 1 mM 
imidazole).  EDTA-free protease inhibitor cocktail (Roche, 1 tablet) and PMSF (1 mM) were 
added just before cell lysis. Cells were lysed by passing through a French Press cell at 15,000 
psi three times, and the lysate was clarified by ultracentrifugation (40,000 rpm, 40 min).  The 
supernatant was incubated with 8 ml IMAC Fastflow6 resin (Ni2+ charged, GE Healthcare) and 
rocked slowly for 3 hours in the presence of 10 mM imidazole.  The supernatant was then 
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A 
21-19/41-mer DNA substrate: 
5’- CGCAGCCGTCCAACCAACTCA CGTCGATCCAATGCCGTCC –3’ 
3’- GCGTCGGCAGGTTGGTTGAGTAGCAGCTAGGTTACGGCAGG -5’ 
 
B 
22-mer
21-mer
1 min     5 min      10 min     15 min         30 min         1 h              2 h         3 h
 
Fig. 3. Pre-steady-state kinetic assay.  A preincubated solution of hPolλ 
mutant and 21-19/41-mer substrate were mixed with a single dNTP for 
various reaction times before quenching with EDTA.  A, 21-19/41-mer 
substrate. B, products are resolved by gel electrophoresis on a 17% 
Acrylamide, 8 M urea, 1 X TBE gel. 
 
removed by centrifugation in a swing bucket centrifuge (2500 rpm, 2.5 min) and the resin was 
packed into the HR-10/10 FPLC column.  The hPol λ bound to the resin was purified through a 
linear gradient of 35–500 mM imidazole in Buffer B (10 mM KHPO4, pH 7.0, 350 mM NaCl, 5—
500 mM Imidazole, 10% Glycerol, 0.05% β-mercaptoethanol).  Fractions containing hPol λ 
were dialyzed for 3 hours against dialysis Buffer C (25 mM HEPES, pH 7.0 at 4° C, 100 mM 
NaCl, 1 mM EDTA, 10% Glycerol, 0.1% β-mercaptoethanol).  The dialyzed protein solution 
was applied to a Heparin Sepharose Fast Flow column (GE Healthcare) and eluted using 100–
1000 mM NaCl in buffer C.  Fractions containing hPol λ were pooled and dialyzed against 
buffer C.  The dialyzed hPol λ was passed through two 5 mL HiTrap Q anion exchange 
columns (GE Healthcare).  The loading elute was applied to two 5 mL HiTrap SP cation 
exchange columns (GE Healthcare) and eluted using a gradient of 100—1000 mM NaCl in 
buffer C.  The fractions containing hPol λ were dialyzed against buffer D (25 mM HEPES, pH 
7.0 at 4° C, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 50% Glycerol) and stored at -80° C.  The 
concentration of the purified hPol λ mutants were measured spectrophotometrically at 280 nm 
using the calculated extinction coefficient 61,615 M-1cm-1. 
Determination of the kp and Kd of an Incoming Nucleotide.  The 21-19/41-mer DNA substrate 
(Fig. 3A) was purified by denaturing polyacrylamide gel electrophoresis and prepared as 
described [11].  A solution 
containing hPolλ (120 nM) 
and 5'-[32P] DNA (30 nM) 
preincubated in buffer L (50 
mM Tris-HCl, pH 8.4 at 37° C, 
5 mM MgCl2, 100 mM 
NaCl, 0.1 mM EDTA, 5 mM 
DTT, 10% glycerol, and 0.1 
mg/mL BSA) was mixed with 
increasing concentrations of a 
single nucleotide. Reactions 
were terminated by the 
addition of 0.37 M EDTA. Products were separated from remaining substrate via sequencing 
gel electrophoresis (17% acrylamide, 8 M urea) (Fig. 3B.) and quantitated using a 
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Fig. 4.  Data Fitting.  A, Solid lines are best 
fits to single-exponential equation.  B, Solid 
line is best fit to hyperbolic equation. 
PhosphorImager 445 SI (Amersham Biosciences). 
The time course of product formation was fit to 
Equation 1 for each concentration of dNTP to yield 
an observed rate constant (kobs) and a reaction 
amplitude (A). The extracted kobs values were then 
plotted as a function of the concentration of dNTP 
and fit to Equation 2 to give kp and Kd. 
 
Data were fit by nonlinear regression using the 
program KaleidaGraph (Synergy Software).  
 
Summary of Results 
Based on the Kd values recorded in Table 1 it was 
concluded that, of the six residues mutated, 
residues R386, A510, and R514 play the major role 
in nucleotide binding.  By examining the crystal 
structure of the tPol λ ternary complex, one can 
readily observe the strong salt bridge formation between the negatively charged γ-phosphate 
on the dNTP and the positively charged guanidinium group on R386.  Although this residue is 
conserved in Pol β, the measured distance of the salt bridge is 6.14 Å [15] which accounts for 
a weaker stabilization when compared to the 4.39 Å distance in the tPol λ ternary structure.  
The mutation of residue A510 to glutamate can also be understood by examining the crystal 
structure, which reveals that the 510 position is sufficiently close to the dNTP that an 
introduced carboxylate would repel the negatively charged α-phosphate of the dNTP.  This 
phenomenon has been observed in Pol β, which has an aspartate at the corresponding 
position in the wild-type enzyme.  A similar difference between tPol λ and Pol β can also be 
(Eq. 1) 
 
[product] = A[1-exp(- kobst)] 
 
(Eq. 2)  
 
kobs = kp[dNTP]/{[dNTP] + Kd} 
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Correct dTTP incorporation: 
Enzyme Kd (µM) Kd ratio
a 
R386A 15 ± 5 5.8 
K422A 7 ± 1 2.5 
F506A 8 ± 4 3.0 
A510E 7 ± 2 2.7 
R514A 12 ± 4 4.6 
Wild-type 2.6 ± 0.4 1 
Incorrect dTTP incorporation: 
Enzyme Kd (µM) Kd ratio
a 
R386A 35 ± 4 11 
K422A 5.5 ± 0.6 1.7 
F506A 19 ± 6 5.9 
A510E 31 ± 20 9.7 
R514A 63 ± 24 20 
Wild-type 3.2 ± 0.5 1 
Table 1.  Measured Kd of nucleotide 
incorporation for all mutants.  
 aCalculated as Kd mutant/ Kd wild-type. 
observed in the instance of Pol λ R514, which 
demonstrates multiple close interactions > 6.5 
Å with the DNA template and the dNTP.  In the 
corresponding residue, K280, in Pol β no 
interactions with the dNTP can be observed in 
the crystal structure [15]. 
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Fig. 5.  Structure of the Dpo4•13-mer/    
18-mer•dADP complex. [3] 
C.  Structure-Function Studies in Sulfolobus solfataricus  DNA polymerase IV (Dpo4) 
Genomic DNA is continually subjected to a myriad of 
endogenous and exogenous DNA damaging agents 
such as UV light, reactive oxygen species, and 
ionizing radiation [16].  Cellular mechanisms that 
repair DNA lesions have evolved, but many lesions 
elude DNA repair pathways and persist, thereby 
impeding DNA replication. In order to survive, cells 
must have the means to carry out DNA replication 
even in the presence of DNA lesions. Canonical DNA 
replication complexes, however, are incapable of 
synthesis through DNA lesions due to their restrictive 
active sites. Stalled replication complexes can be saved by the recruitment of a novel class of 
enzymes known as the Y-family DNA polymerases.  The recently discovered Y-family DNA 
polymerases can be found in all domains of life and have been shown to be capable of 
translesion synthesis [17].  The ability to carry out lesion bypass is granted by a relatively 
flexible active site that can accommodate aberrant base pairing geometries. Consequently, the 
Y-family polymerases are characterized by a low-processivity and demonstrate low-fidelity.   
Because of its ease of purification [18] and ability to carry out tranlesion synthesis, Sulfolobus 
solfataricus DNA polymerase IV (Dpo4), has served as a model Y-family enzyme in a variety of 
studies in our lab [18-21], and continues to provide more avenues for fruitful research.  Four 
studies with Dpo4 are described in this report.  In the first project the nature of a region of 
Dpo4 known as the linker region was interrogated in the context of DNA binding.  The next two 
studies were more biophysical in nature, with the first being an attempt to crystallize Dpo4 in 
the presence of a blunt-ended DNA substrate and an incoming nucleotide, and the second 
being a fluorescence up-conversion assay to probe the dynamics of the enzyme active site.   
Lastly, Dpo4 has been used in a protein engineering effort with the ultimate goal of engineering 
a fused construct of Dpo4 and an ATP-dependent translocase that will effectively motor the 
polymerase along a single-stranded DNA substrate. 
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Enzyme Linker Sequence KD 
WT RDEYNEPIRTRVRK 10 nM 
1 Gly Addition RDEYNEPIGRTRVRK 118 nM 
4 Gly Addition RDEYNEPIGGGGRTRVRK 279 nM 
6 Gly Addition RDEYNEPIGGGGGGRTRVRK 674 nM 
1 Deletion RDEYNEP-RTRVRK 159 nM 
4 Deletion RDEY----RTRVRK 304 nM 
6 Deletion RD------RTRVRK 1688 nM 
Table 2.  DNA binding data for Dpo4 linker mutants. 
1.  DNA Binding Studies with Dpo4 All Glycine Linker and Dpo4-Dbh Linker Swap:   
By studying a model Y-family polymerase, Sulfolobus solfataricus DNA Polymerase IV, we 
seek to investigate the role of a unique domain known as the little finger, which is thought to 
grant this enzyme its essential lesion bypass characteristics [3, 17, 22].  The little finger 
domain in Dpo4 is tethered to the core of the polymerase by a filament called the linker region. 
Preliminary work has shown that the size of the linker region significantly affects the enzyme’s 
ability to form stable binding complexes with primed DNA substrates.  By generating a series 
of mutant Dpo4 enzymes, each with a linker region of different size, and measuring the 
ground-state DNA binding affinity (Kd ) using gel electrophoretic mobility shift assays and 
fluorescence titration assays (Jun Zhang and Suo, unpublished data) (Table 2 ) we 
hypothesize that the linker size has been optimized by nature for the best possible DNA 
binding. However, this data leaves 
many unanswered questions 
regarding the linker region’s role in 
DNA binding.  The most notable 
ambiguity is the impact that amino 
acid composition may have 
regarding the linker region’s 
interactions with DNA.  Therefore, 
we began a series of studies in 
which the size of the linker region is left unmodified, but the amino acid composition will be 
varied using site directed mutagenesis.  The first mutation assayed was an “all-glycine linker” 
mutant in which all of the original 14 amino acid residues in the linker region were mutated to 
glycine.  Glycine was chosen for this purpose because it has no side chains that may interact 
with the DNA and it also confers the most flexibility to the peptide backbone [23]. The second 
mutation assayed was the Dpo4-Dbh linker swap mutant.  This mutation was inspired by the 
work of Boudsocq et. al. which demonstrated that by swapping the linker region and little finger 
domains of Dpo4 and Dbh the enzymatic properties could be also be “swapped.” By assaying 
these mutants we will better understand the role of this novel domain in lesion bypass 
catalyzed by the Y-family polymerases. 
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Experimental Procedures 
Generation of the Dpo4 All-glycine linker Mutant and Dpo4-Dbh linker swap Mutant.  
Synthetic oligonucleotide primers (Table 3) were used to generate the Dpo4 linker mutants via 
a site-directed mutagenesis kit using Pfu Turbo (Stratagene).  The Dpo4-Dbh linker swap 
mutant was generated over three rounds, with the plasmid resulting from each round serving 
as the template for the subsequent rounds of mutagenesis.  The 14 amino acid sequence of 
the Dpo4 linker (RDEYNEPIRTRVRK) was mutated to that of Dbh (RNKYSEPVENKSKI).  The 
Dpo4 all-glycine linker mutant was generated using one round of mutagenesis.  PCR was 
carried out for 18 cycles (denaturation, 95° C for 30 sec; annealing, 48° C for 1 min; extension, 
68° C for 14 min) and after DpnI digestion the amplified products were transformed into the XL-
10 Gold E.coli strain (Stratagene).  Mutant plasmids were purified from transformed cells using 
the Wizard Plus SV Miniprep kit (Promega) and sequences were confirmed by OSU Plant 
Microbe Genomics Facility.  
 
Purification of the Dpo4 All-Glycine linker and Dpo4-Dbh Linker swap mutants.  The C-
terminal His6-tagged Dpo4 All-gly linker and Dpo4-Dbh Linker swap plasmids (pET 22b+) were 
transformed into BL21(DE3) RIL chemical competent cells by heat shock (42° C for 45 
seconds).  An overnight culture of E. coli expression strain BL21(DE3) RIL carrying the Dpo4 
plasmid was used to inoculate Luria-Bertani medium containing 100 µg/mL ampicilan, and the 
cells were grown at 37° C until OD600 = 0.6.  The cultures were induced with 0.15 mM IPTG 
and incubated at 30° C for 5.5 h (OD600 ~1.7).  Induced cells were harvested (4000 rpm,15 
min) and resuspended in Buffer A (10 mM KHPO4, pH 7.0, 50 mM NaCl, 10 mM MgCl2, 10% 
glycerol, 0.1% beta-mercaptoethanol, 1 mM imidazole).  PMSF (1 mM) was added just before 
the cells were lysed by passing through a French Press cell at 15,000 psi three times, and the 
Table 3.  DNA primers for Site-Directed-Mutagenesis 
Dbh  
L-1 
Forward 5'-GAGTATAACGAGCCTGTAGAAAATAGATCAAAAATCAGTATTGGGAGAATTG -3' 
Reverse 5'-CAATTCTCCCAATACTGATTTTTGATCTATTTTCTACAGGCTCGTTATACTC -3' 
Dbh  
L-2 
Forward 5'-GCTAAGGCTAAATATCTGATCTCTCTAGCCAGAGACGAGTATAAC -3' 
Reverse 5'-GTTATACTCGTCTCTGGCTAGAGAGATCAGATATTTAGCCTTAGC -3' 
Dbh  
L-3 
Forward 5'-CTGATCTCTCTAGCCAGAAACAAGTATAGCGAGCCTGTAGAAAATAG -3' 
Reverse 5'-CTATTTTCTACAGGCTCGCTATACTTGTTTCTGGCTAGAGAGATCAG -3' 
All  
Gly 
Forward 5’-GCTAGAGACGGGGGTGGCGGGGGTGGAGGAGGTGGAGGAGGAGGGAGTATTGGG –3’ 
Reverse 5’–CCCAATACTCCCTCCTCCTCCACCTCCTCCACCCCCGCCACCCCCGTCTCTAGC -3’ 
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lysate was clarified by ultracentrifugation (40,000 rpm, 40 min).  Cleared lysate was subjected 
to heat denaturation at 78° C for 12 min to precipitate thermolabile E. coli proteins which were 
then removed by ultracentrifugation (40,000 rpm, 40 min).  The supernatant was incubated 
with 8 ml IMAC Fastflow6 resin (Ni2+ charged, GE Healthcare) and rocked slowly for 3 hours in 
the presence of 10 mM imidazole.  The supernatant was then removed by centrifugation in a 
swing bucket centrifuge (2500 rpm, 2.5 min) and the resin was packed into a HR-10/10 FPLC 
column (GE Healthcare).  The Dpo4 bound to the resin was purified through a linear gradient 
of 35–500 mM imidazole in Buffer B (10 mM KHPO4, pH 7.0, 350 mM NaCl, 5–500 mM 
imidazole, 10% Glycerol, 0.05% β-mercaptoethanol).  Fractions containing Dpo4 were dialyzed 
for 3 hours against dialysis Buffer C (50 mM Tris-HCl, pH 7.5 at 25° C, 50 mM NaCl, 1 mM 
EDTA, 10% Glycerol, 0.1% β-mercaptoethanol).  The dialyzed protein solution was passed 
through two 5 mL HiTrap Q anion exchange columns (GE Healthcare).  The loading elute was 
applied to two 5 mL HiTrap SP cation exchange columns (GE Healthcare) and eluted using a 
gradient of 100—1000 mM NaCl in buffer C.  The fractions containing Dpo4 were dialyzed 
against buffer D (25 mM HEPES, pH 7.0 at 4° C, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 50% 
Glycerol) and stored at -80° C.  The concentrations of the purified Dpo4 mutants were 
measured spectrophotometrically at 280 nm using the calculated extinction coefficient 24,580 
M-1cm-1.   
Fluorescence Titration Assay.  The 
binding affinity of the Dpo4 mutant 
enzymes for a DNA duplex was carried out 
using a fluorescence titration assay.  
Varying concentrations of Dpo4 (6.3-300 
nM) were titrated into a quartz cuvette 
containing a 23/34-mer 2-Aminopurine (2-
AP)-embedded substrate (Fig. 6).  The 
excitation wavelength for the Dpo4•23/34-
mer duplex was 310 nm, and the emission 
was recorded from 360–400 nm.  All 
quantitation was carried out using the emission at 370 nm.  Emission intensity was corrected to 
measure the contribution of the Dpo4•DNA complex only by subtracting the emission of buffer 
A 
 
 
B 
5′-CGCAGCCGTCCAACCAACTCAG-3′ 
3′-GCGTCGGCAGGTTGGTTGAGTCXCAGCTAGGTTA-5′ 
Fig. 6.  A, 2-AP structure.  B, 23/34-mer DNA 
substrate.  Bold ‘X’ indicates 2-AP. 
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alone and DNA alone contribution.  The resulting fluorescence was fit to a quadratic binding 
equation (Eq. 4), which was derived from Equation 3 by substituting the fluorescence signal for 
[ES]. 
 
 
 
 
 
 
 
Summary of Results 
Using a fluorescence titration assay a Kd of 6.7 nM was obtained for the Dpo4 Dbh linker 
swap mutant and the exact quantitation of the Kd for the Dpo4 all-glycine linker mutant has 
been delayed by technical complications with the fluorometer, however our preliminary results 
indicate that the DNA binding affinity of the all-glycine mutant is comparable to that of wild-
type.  The Kd value of the Dpo4 Dbh linker swap mutant differs only slightly from the wild-type 
Kd of 4.5 nM.  Based on these results we can conclude that linker size, as opposed to 
sequence, is the key factor in determining the strength of DNA binding by the Dpo4 enzyme.  
These results also indicate that the unique enzymatic properties granted by the little finger 
domain [22]  are not dependent on the composition of the linker region despite the fact that 
only 29% homology is shared between Dpo4 and Dbh in the 14 amino acid linker region.
(Eq. 3) 
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Table 4.  DNA substrates. 
Dpo4•13-mer/18-mer•dATP 
5’-GGCTACAGGACTC-3’      13mer  
3’-CCGATGTCCTGAGTACTT-5’ 18mer 
 
Dpo4•13-mer/13-mer•dATP 
5’-GGCTACAGGACTC-3’      13mer 
3’-CCGATGTCCTGAG-5’      13mer 
 
2.  Crystallization of Dpo4•13-mer/18-mer•dATP and Dpo4•13-mer/13-mer•dATP Ternary 
Complexes: 
Recent studies of the reverse transcriptase enzyme encoded by the human 
immunodeficiency virus 1 reveal a unique ability to make single nucleotide additions to blunt-
ended DNA substrates [24, 25].  This activity offers a plausible mechanism by which the HIV-1 
virus is able to mutate with such high efficiency and thus elude contemporary medicine’s best 
efforts to eradicate the virus from our population [25, 26].  The model enzyme Dpo4 was used 
to interrogate the mechanism such blunt-end additions to DNA.  Previous kinetic experiments 
have shown this model enzyme to be capable of similar blunt-end addition as described for 
HIV1-RT.  In order to determine the structure by x-ray crystallographic methods, we sought to 
crystallize a ternary complex of the enzyme, blunt-ended DNA substrate, and an incoming 
deoxynucleotide.  A complete structure, through analysis of the geometry of the ternary 
complex, would provide strong evidence for the proposed mechanism of single nucleotide 
addition at free DNA blunt ends.  It was our expectation that the incoming nucleoside 
triphosphate would form an interstrand base stacking interaction with the 5’ end of the template 
DNA.  This base stacking could provide an adequate amount of energy to temporarily 
immobilize the nucleoside triphosphate in an orientation that is favorable for the chemistry of 
phosphodiester bond formation.  In working toward this goal a structure for the ternary complex 
with a blunt-ended DNA substrate was not obtained in our 
lab, but instead by our collaborator, Dr. Hong Ling.  While 
we were unsuccessful in generating diffracting crystals with 
the blunt-ended substrate, we were able to obtain crystals 
and solve the structure of the control setup which 
contained a 13/18-mer DNA substrate. 
 
Experimental Procedures 
Purification of Native Dpo4.  The native Dpo4 plasmid (p1914) was transformed into 
BL21(DE3) electrocompetent cells by electroporation.  An overnight culture of E. coli 
expression strain BL21(DE3) carrying the native Dpo4 plasmid was used to inoculate Luria-
Bertani medium containing 100 µg/mL ampicilan, and the cells were grown at 37° C until OD600 
= 0.6.  The cultures were induced with 0.2 mM IPTG and incubated at 34° C for 4.5 h (OD600 
Newmister 15 
 
Fig. 7. Hanging-drop vapor 
diffusion apparatus 
~1.7).  Induced cells were harvested (4000 rpm,15 min) and resuspended in Buffer A (10 mM 
KHPO4, pH 7.0, 50 mM NaCl, 10 mM MgCl2, 10% glycerol, 0.1% beta-mercaptoethanol).  
PMSF (1 mM) was added just before the cells were lysed by passing through a French Press 
cell at 15,000 psi three times, and the lysate was clarified by ultracentrifugation (40,000 rpm, 
40 min).  Cleared lysate was subjected to heat denaturation at 80° C for 12 min to precipitate 
thermolabile E. coli proteins which were then removed by ultracentrifugation (40,000 rpm, 40 
min).  The supernate was applied to a Heparin Sepharose column (GE Healthcare) and eluted 
by a linear gradient (50–1000 mM NaCl) in buffer B (20 mM HEPES, pH 7.0 at 4°C, 100 mM 
NaCl, 1 mM EDTA, 10% Glycerol, 0.1% β-mercaptoethanol).  Fractions containing Dpo4 were 
dialyzed against buffer B (50 mM NaCl) for 3 h at 4° C. The dialyzed protein solution was 
passed through two 5 mL HiTrap Q anion exchange columns (GE Healthcare).  The loading 
elute was applied to two 5 mL HiTrap SP cation exchange columns (GE Healthcare) and 
eluted using a gradient of 100—1000 mM NaCl in buffer B.  The fractions containing Dpo4 
were dialyzed against buffer C (20 mM HEPES, pH 7.0 at 4° C, 100 mM NaCl, 1mM DTT, 
5mM MgCl2, 2.5% glycerol) for 3 h at 4° C, and the dialyzed protein solution was concentrated 
to 16 mg/mL (381 µM) using a Centriprep YM-10 apparatus.  The concentration of the purified 
Dpo4 was measured spectrophotometrically at 280 nm using the calculated extinction 
coefficient 24,580 M-1cm-1.   
Synthetic Oligonucleotides.  DNA substrates were purified using polyacrylamide gel 
electrophoresis and desalted using reverse-phase chromatorgraphy (Sep-pack C18).  The 
concentration of the DNA primers was measured spectrophotometrically using the extinction 
coefficients provided by the manufacturer (Integrated DNA Technologies; 13-mer: 123,300 M-1 
cm-1, 18-mer 166,500 M-1cm-1).  The 13-mer substrate was dideoxy-terminated at the 3’ end in 
order to prevent reaction with the incoming dATP, which would result in a heterogeneous 
mixture of DNA substrate in the complex. 
Crystallization Conditions.  The optimal conditions for 
crystallization of Dpo4 were established in 2001 [3], and the 
setup for both the Dpo4•13-mer/18-mer•dATP and the 
Dpo4•13-mer/13-mer•dATP complexes were based on only 
slight variation from the optimal conditions for the well solution 
(16% PEG 3350, 0.1 M HEPES, pH 7.0, 100 mM Ca(OAc)2, 
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Fig. 8.  Crystal (left) and X-ray diffraction pattern (right) of Dpo4•13-mer/18-mer•dATP 
complex.  Resolution observed at OSU X-ray diffraction facility: 2.5 Å. 
2.5% glycerol) and drop solution  (60 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1 mM dATP, 8 
mg/mL Dpo4, 228.6 µM DNA, 20 mM HEPES, pH 7.0, 2.5% glycerol).  Numerous hanging 
drop vapor diffusion apparatus were set up using the stated conditions, and others were set up 
with slight variations in pH (6.75–7.25) and PEG (10–16%).  In all cases the ratio of DNA:Dpo4 
was held at a constant 1.12:1 ratio [3].  After set up the trays were left undisturbed at 25° C for 
48 h before being examined for crystal growth. 
 
Summary of Results 
While the ultimate goal of this project was in fact to obtain diffracting crystals of the Dpo4•13-
mer/13-mer•dATP complex in order to understand the mechanism of blunt-end addition by a  
DNA polymerase, the task was ultimately deferred to our collaborator Dr. Hong Ling.  We were 
able to obtain diffracting crystals (Fig. 8) of the Dpo4•13-mer/17-mer•dATP complex and the 
structure was solved using the molecular replacement technique by Jason Fowler, a gradient 
student in our lab.  The structure for this complex has already been solved [3], but the our 
efforts were regardless a worthwhile exercise in the crystallization of polymerases, and the 
results of the blunt-end addition study were published in 2007 [19], using the structure 
provided by Dr. Hong Ling. 
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3.  Purification of Dpo4 Y12W and Y312W Mutants: 
Fluorescence spectroscopy of the aromatic amino acid residues offers a very sensitive probe 
in detecting protein molecular conformational changes. Sometimes rather subtle changes in 
the conformation of a protein give rise to fairly large changes in the fluorescence 
characteristics, whereas other physical methods fail to show any change [1].  Since the protein 
conformational changes take place very quickly, the events have to be resolved on a pico or 
femto second scale. The femtosecond resolved fluorescence of a protein containing a single 
tryptophan residue using LASER are used to study the dynamics of protein function. The 
fluorescence intensity is affected by specific interactions and by solvent and environmental 
factors (hydration).  
 
 
 
 
 
 
 
 
 
 
Dpo4, a Y-family DNA polymerase from 
Sulfolobus solfataricus is can bypass various 
DNA lesions. It has 16 tyrosine residues 
whereas no tryptophan residues.  In order to 
probe the dynamics of Dpo4 function, Dpo4 was 
mutated to contain a single tryptophan residue at 
its active site (Y12W) and purified to near 
homogeneity. The Y12 residue is located in the 
finger domain. As a control another Dpo4 mutant 
with tryptophan on the surface (Y312W) was 
made and purified. 
 
Fig. 10.  Close view of Dpo4 active site.  Y12 
is shown in close proximity to the incoming dATP 
(left) [3]. 
 
Fig.9. Timescale of fundamental motions, chemistry, and dynamics [1]. 
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Experimental Procedures 
Generation of Dpo4 Y12W and Y312W.  The single substitution mutants were generated 
using site-directed mutagenesis by the students in Dr. Suo’s Biochemistry 521 course. 
Purification of Dpo4 Y12W and Y312W.  The C-terminal His6-tagged Dpo4 Y12W and 
Y312W plasmids (pET 22b+) were transformed into BL21 (DE3) chemical competent cells by 
heat shock (42° C for 45 seconds).  An overnight culture of E. coli expression strain 
BL21(DE3) carrying the Dpo4 plasmid was used to inoculate Luria-Bertani medium containing 
100 µg/mL ampicilan, and the cells were grown at 37° C until OD600 = 0.6.  The cultures were 
induced with 0.15 mM IPTG and incubated at 30° C for 5.5 h (OD600 ~1.7).  Induced cells were 
harvested (4000 rpm,15 min) and resuspended in Buffer A (10 mM KHPO4, pH 7.0, 50 mM 
NaCl, 10 mM MgCl2, 10% glycerol, 0.1% beta-mercaptoethanol, 1 mM imidazole).  PMSF (1 
mM) was added just before the cells were lysed by passing through a French Press cell at 
15,000 psi three times, and the lysate was clarified by ultracentrifugation (40,000 rpm, 40 min).  
Cleared lysate was subjected to heat denaturation at 78° C for 12 min to precipitate 
thermolabile E. coli proteins which were then removed by ultracentrifugation (40,000 rpm, 40 
min).  The supernatant was incubated with 10 ml IMAC Fastflow6 resin (Ni2+ charged, GE 
Healthcare) and rocked slowly for 3 hours in the presence of 10 mM imidazole.  The 
supernatant was then removed by centrifugation in a swing bucket centrifuge (2500 rpm, 2.5 
min) and the resin was packed into a HR-10/10 FPLC column (GE Healthcare).  The Dpo4 
bound to the resin was purified through a linear gradient of 35–500 mM imidazole in Buffer B 
(10 mM KHPO4, pH 7.0, 350 mM NaCl, 5–500 mM Imidazole, 10% Glycerol, 0.05% β-
mercaptoethanol).  Fractions containing Dpo4 were dialyzed for 3 hours against dialysis Buffer 
C (50 mM Tris-HCl, pH 7.5 at 25° C, 50 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.1% β-
mercaptoethanol).  The dialyzed protein solution was passed through two 5 mL HiTrap Q anion 
exchange columns (GE Healthcare).  The loading elute was applied to three 5 mL HiTrap SP 
cation exchange columns (GE Healthcare) and eluted using a gradient of 100—1000 mM NaCl 
in buffer C.  The fractions containing Dpo4 were dialyzed against buffer D (50 mM Tris-HCl, pH 
7.5 at 25° C, 300 mM NaCl, 1 mM EDTA, 10% Glycerol) for 3 h at 4° C.  TCEP (1 mM) was 
added to the protein solution which was concentrated using a Centriprep YM-10 apparatus.  
The protein solution was examined every 5 min during concentration to ensure that no 
precipitation had occurred.  The concentrations of the purified Dpo4 mutants were measured 
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spectrophotometrically at 280 nm using the calculated extinction coefficient 26,360 M-1cm-1 and 
stored at -80° C.  The final concentration for Dpo4 Y12W was 343 µM and 350 µM for Dpo4 
Y312W.  High protein concentration was needed to provide sufficient signal for fluorescence 
up-conversion assays.  Dpo4 could not be concentrated beyond 350 µM without precipitation. 
 
Summary of Results 
Upon purification and concentration, the Dpo4 Y12W and Y312W mutants were given to our 
collaborator Dr. Dongping Zhong in the Department of Physics at OSU. All results obtained 
thus far have proved inconclusive.  The Y12W and Y312W mutants demonstrate a 
fluorescence change that is comparable in magnitude.  This could be due to two phenomena: 
(1) that the Y312W mutant is not serving as a control in the manner we anticipated because 
the nature of solvation changes during the catalytic cycle, or (2) high NaCl concentrations in 
buffer D have resulted in a substantial reduction in enzyme activity, which reduces the 
anticipated fluorescence of the Y12W mutant.  
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Fig. 11.  Cloning strategy.  A, Schematic of the Dpo4 gene in pET 
22b+.  B, Insertion of E.coli UvrD between newly-engineered HinDIII 
and XhoI sites. 
4.  Generation of E.coli UvrD•Dpo4 Fusion Construct 
In this project it was our aim to generate a fusion protein which tethered a DNA polymerase 
to an ATP-dependent translocase in an attempt to amplify the processivity of Dpo4, a non-
processive enzyme.  We planned to fuse a motor protein at the C-terminus of Dpo4 in order to 
provide it with the ATP-dependant energy required to translocate along template DNA.  
Translocases/helicases are one of the best studied classes of DNA translocating enzymes. In 
order to select candidate motor protein for Dpo4, the translocase/helicase proteins from 
archaea and bacteria were examined. The archaeal enzymes are not well characterized in 
terms of their kinetics, processivity, or oligomeric status.  The bacterial translocases, however, 
have been well characterized, e.g. Rep helicase, RecBCD and Helicase II (UvrD) and PcrA. 
The E. coli Rep helicase and PcrA from gram negative bacteria have high rates of 
translocation but only moderate processivity [27].  E. coli helicase II (UvrD) has high 
processivity of DNA translocation and it is capable of translocating ssDNA in 3’ to 5’ direction 
in monomeric form [28].  Based on these facts the UvrD translocase/helicase was selected to 
fuse with Dpo4. It is encoded by the uvrD gene and functions in a number of DNA repair 
processes including (i) methyl directed mismatch repair and (ii) excision repair [28, 29]. It is 
DNA dependant helicase and 
belongs to superfamily I of DNA 
helicases. At low concentrations 
it preferentially unwinds duplex 
DNA with 3’ single-stranded tails 
but at higher concentrations it 
can initiate DNA unwinding at 
blunt ends and at nicks [28]. 
Hence it is believed to unwind 
duplex DNA during these repair 
processes, however its 
mechanism of unwinding is not 
fully known. 
 
 
Newmister 21 
Experimental Procedures 
In order to obtain a Dpo4•UvrD fusion construct the cloning strategy in Fig.10 was devised, in 
which the UvrD gene is attached to the C-terminus of Dpo4 via a poly-glycine linker.  While the 
experimental approach for this study has been designed in its entirety, the execution is lacking 
and a full-length fusion construct has yet to be generated.  Described below is the work that 
has been done to date on this project. 
Generation of UvrD insert.  HindIII and XhoI restriction sites were added to the UvrD gene via 
mutagenic PCR (35 cycles: denturation, 95° C for 30 sec; annealing, 48° C for 10 min; 
extension, 68° C for 7 min) using the mutagenic primers UvrD-HinDIII Forward 5’–
CATAAGCTTATGGACGTTTCTTACCTGCTCGACAGCC-3’ and UvrD-XhoI Reverse: 5’ –
GTGGAGCTCCACCGACTCCAGCCG -3’.  The PCR product was digested with HindIII and XhoI 
(New England Biolabs).  The size of the insert was confirmed using a using a 0.8% agarose 
gel and the digested UvrD gene was purified using a QIAquick Gel Extraction Kit (Qiagen). 
Insertion of the HindIII and poly-glycine linker into Dpo4 vector.  Synthetic oligonucleotide 
primers (Table 5) were used to introduce the HindIII and poly-glycine linker into the Dpo4 gene 
via a site-directed mutagenesis kit using Pfu Turbo (Stratagene).  The PCR was carried out for 
18 cycles (denaturation, 95°C for 30 sec; annealing, 55°C for 1 min; extension, 68°C for 14 
min) and after DpnI digestion the amplified products were transformed into the XL-10 Gold 
E.coli strain (Stratagene).  Mutant plasmids were purified from transformed cells using the 
Wizard Plus SV Miniprep kit (Promega) and sequences were confirmed by OSU Plant Microbe 
Genomics Facility.  
Summary of Results 
The full length fusion construct has yet to be generated.  Progress on this project ceased 
upon the departure of Dr. Basavaraj Bagewadi, a postdoctoral fellow in our lab.  Work will 
resume with the ligation of the UvrD insert to the calf-intestine alkaline phosphotase (CIAP)-
Table 5. DNA Primers for HindIII and poly-glycine linker in Dpo4 
HindIII 
3-Gly 
Forward 5'-CAAGTTCTTCGATACTGGAGGTGGAAAGCTTGCACTCGAGCACCACCAC -3' 
Reverse 5'-GTGGTGGTGCTCGAGTGCAAGCTTTCCACCTCCAGTATCGAAGAACTTG -3' 
6-Gly I 
Forward 5'-CAAGTTCTTCGATACTGGAGGTGGAGGTGGAGGTGGAGGTGGAAAGCTTG -3' 
Reverse 5'-CAAGCTTTCCACCTCCACCTCCACCTCCACCTCCAGTATCGAAGAACTTG -3' 
6-Gly II 
Forward 5’-CAAGTTCTTCGATACTGGGGGAGGTGGAGGTGGAGGAGGTGGAGGTGGAGG -3’ 
Reverse 5’-CAATTCTCCCAATACTGATTTTTGATCTATTTTCTACAGGCTCGTTATACTC -3’ 
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digested Dpo4 (with HindIII restriction site and poly-glycine linker) vector.  The ligation will be 
carried out using T4 DNA ligase (New England Biolabs) overnight at 16° C.  Upon generation 
of the full-length construct the next challenge will be purification of the fusion protein.  The C-
terminal His6 tag on the Dpo4 vector will provide the first purification step, and a column which 
mimics DNA structure such as the Heparin Sepharose (GE Healthcare) may be used to further 
purify the fusion construct.  Assuming that it could be purified, we would use DNA substrates of 
varying length to compare the processivity of wild-type Dpo4 to that of the fusion construct. 
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D.  Purification of Human DNA Polymerase κ (hPol κ) and Mouse DNA Polymerase κ 
(mPol κ) 
Human Y-family DNA polymerases are known to be capable of translesion synthesis [5], but 
the bypass of DNA lesions can be done in an error-free or an error-prone manner [30].  For 
that reason members of our lab have launched a project in which the mutational profile that 
results from the bypass process catalyzed by the human Y-family DNA polymerases η, κ, and ι 
on damaged DNA templates were quantitatively analyzed by a novel short oligonucleotide 
sequencing assay [21]. DNA polymerase κ was purified as a part of the project which aims to 
establish the outcome of translesion synthesis by Y-family DNA polymerases.  The methods 
for this project have been designed in our lab and published in 2007 [21] with a model Y-family 
DNA polymerase, Dpo4. 
 
Experimental Procedures 
Purification of mPol κ.  The N-terminal His6-tagged mPol κ plasmid (pET 16b) was 
transformed into BL21(DE3) Rosetta chemical competent cells by heat shock (42° C for 45 
seconds).  An overnight culture of E. coli expression strain BL21(DE3) Rosetta carrying the 
mPol κ plasmid was used to inoculate Luria-Bertani medium containing 100µg/mL ampicilan, 
and the cells were grown at 37° C until OD600 = 0.6.  The cultures were induced with 0.15 mM 
IPTG and incubated at 19° C for 10 h (OD600 ~1.7).  Induced cells were harvested (4000 
rpm,15 min) and resuspended in Buffer A (10 mM KHPO4, pH 7.0, 300 mM NaCl, 10 mM 
MgCl2, 10% glycerol, 0.1% beta-mercaptoethanol, 1 mM imidazole).  EDTA-free protease 
inhibitor cocktail (Roche, 1 tablet) and PMSF (1 mM) were added just before the cells were 
lysed by passing through a French Press cell at 15,000 psi three times. The lysate was 
clarified by ultracentrifugation (40,000 rpm, 40 min), and the supernatant was incubated with 
10 ml IMAC Fastflow6 resin (Ni2+ charged, GE Healthcare) and rocked slowly for 3 hours in the 
presence of 10 mM imidazole.  The supernatant was then removed by centrifugation in a swing 
bucket centrifuge (2500 rpm, 2.5 min) and the resin was packed into a HR-10/10 FPLC column 
(GE Healthcare).  The mPol κ bound to the resin was purified through a linear gradient of 35–
500 mM imidazole in Buffer B (10 mM KHPO4, pH 7.0, 350 mM NaCl, 5–500 mM imidazole, 
10% Glycerol, 0.05% β-mercaptoethanol).  Fractions containing mPolκ were dialyzed for 3 
hours against dialysis Buffer C (50 mM Tris-HCl, pH 7.5 at 25° C, 50 mM NaCl, 1 mM EDTA, 
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10% Glycerol, 0.1% β-mercaptoethanol).  The dialyzed protein solution was applied to two 5 
mL HiTrap Q anion exchange columns (GE Healthcare), and eluted via a three-step gradient 
(100–150 mM NaCl, 150 mM NaCl, 150–1000  mM NaCl) in buffer C. Fractions containing 
mPol κ were dialyzed against buffer D (20 mM Tris—HCl, pH 7.5 at 25° C, 150 mM NaCl, 1 
mM EDTA, 10% glycerol, 0.1% β-mercaptoethanol) for 3 h at 4° C.  The dialyzed protein 
solution was concentrated to 4 mL using a CentriPrep YM-50 apparatus and applied to a 
HiLoad 26/60 Sephacryl 200 gel filtration column (GE Healthcare) and eluted in buffer D (150 
mM NaCl).  Fractions containing purified mPol κ were dialyzed against buffer E (25 mM 
HEPES, pH 7.5 at 4° C, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 50% Glycerol) and stored at -
80° C.  The concentration of the purified mPol κ was measured spectrophotometrically at 280 
nm using the calculated extinction coefficient 31860 M-1cm-1. 
Pufification of hPol κ.  hPol κ was purified by the same method as mPol κ with the exception 
that a Heparin Sepharose column (GE Healthcare) was used in addition to the columns used 
for mPol κ.  hPol κ was eluted from the column using a linear gradient (150–1000 mM NaCl) in 
buffer C.  Fractions containing hPol κ were then dialyzed against buffer E and stored at -80° C 
The concentration of the purified mPol κ was measured spectrophotometrically at 280 nm 
using the calculated extinction coefficient 32,100 M-1cm-1. 
 
Summary of Results 
By analyzing the mutational profile demonstrated 
by mPolκ on a DNA substrate containing an 
abasic site analogue (tetrahydrofuran, THF) it 
has been demonstrated that mPol κ 
preferentially incorporates adenine opposite an 
abasic site (28 of 44 colonies, 64%) (Pryor and 
Suo unpublished results), while also showing a 
proclivity (14%) to generate double deletions 
that would result in frameshift mutations.  In the 
future similar studies will be done with other 
DNA lesions and the human pol κ enzyme. 
 
Fig. 12.  Gel image showing the activity of 
mPolκ.  A, mPolκ was given 3 h to synthesize an 
undamaged 14/51-mer substrate (left) to full 
length product.  B, mPolκ efficiently bypasses an 
abasic site analogue (THF) in the same time 
frame. 
A B 
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E.  Purification of Sulfolobus solfataricus DNA Polymerase B1 (SSo Pol B1) D231A, 
E233A, D318A Triple Substitution Mutant 
The Sulfolobus solfataricus (Sso) genome contains two functional DNA polymerases: Dpo4 
and PolB1 [31].  Because the organism survives with only two DNA polymerases, we would 
like to investigate the mechanism of action of these polymerases using pre-steady-state 
kinetics.  PolB1 is considered to be the polymerase that is responsible for bulk DNA synthesis 
during replication, and unlike Dpo4 it stalls at the site of DNA lesions (Fig. 13).  Much 
mechanistic insight has already been gained with Dpo4 [18], but similar analysis has not been 
performed with PolB1.  In order to use pre-steady-state kinetics to dissect the mechanism for 
PolB1 it is first necessary to eliminate the robust intrinsic exonuclease activity demonstrated by 
PolB1 [31].  Intrinsic exonuclease activity places a severe limitation on any kinetic assay to 
examine the DNA polymerase activity. In order to eliminate the exonuclease activity of PolB1 
site-directed mutagenesis was used to mutate to alanine the conserved aspartic acid and 
glutamic acid residues that bind catalytic metal ions in the exonuclease domain.   Residues 
essential for exonuclease activity were identified using a sequence alignment of the Sso PolB1 
gene with other replicative DNA polymerases [31].  Based on the sequence alignment and 
structural evidence [32] the residues D231, E233, D318, and D413 were identified as the 
residues responsible for 
chelating the two catalytic 
Mg2+ ions in the Sso PolB1 
active site.   Three of the 
four conserved residues 
were selected for mutation 
to alanine.  The D231A, 
E233A, D318A PolB1 triple 
mutant will be tested for 
residual exonulease activity 
after the DNA substrates 
are available. 
 
  
Fig. 13.  SSo PolB1 stalled by an abasic site.  A, undamaged 17/41-mer.  
B, 17/41-mer with an embedded abasic site analogue in template.  Pol B1 
is unable to synthesize beyond the lesion. 
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Experimental Procedures 
Generation of the PolB1 D231A, E233A, D318A exonuclease deficient mutant.  Synthetic 
oligonucleotide primers (Table 6) were used to introduce the single amino acid substitutions 
into the PolB1 gene via a site-directed mutagenesis kit using Pfu Turbo (Stratagene).  The first 
two substitutions (D231A and E233A) were carried out first and the resulting plasmid was used 
as a template for the D318A mutation.  PCR was carried out for 18 cycles (denaturation, 95°C 
for 30 sec; annealing, 55°C for 1 min; extension, 68°C for 14 min) and after DpnI digestion the 
amplified products were transformed into the XL-10 Gold E.coli strain (Stratagene).  Mutant 
plasmids were purified from transformed cells using the Wizard Plus SV Miniprep kit 
(Promega) and sequences were confirmed by OSU Plant Microbe Genomics Facility.  
  
 
 
 
 
Purification of Sso Pol B1 D231A, E233A, D318A.  The N-terminal His6-tagged PolB1 
D231A, E233A, D318A plasmid (pET34b) was transformed into BL21(DE3) Rosetta chemical 
competent cells by heat shock (42° C for 45 seconds).  An overnight culture of E. coli 
expression strain BL21(DE3) Rosetta carrying the polB1 plasmid was used to inoculate Luria-
Bertani medium containing 50 µg/mL kanamycin and 25 µg/mL chloramphenicol, and the cells 
were grown at 37° C until    OD600 = 0.6.  The cultures were induced with 0.15 mM IPTG and 
incubated at 25° C for 7.5 h (OD600 ~1.7).  Induced cells were harvested (4000 rpm,15 min) 
and resuspended in Buffer A (10 mM KHPO4, pH 7.0, 50 mM NaCl, 10 mM MgCl2, 10% 
glycerol, 0.1% beta-mercaptoethanol, 1 mM imidazole).  EDTA-free protease inhibitor cocktail 
(Roche, 1 tablet) and PMSF (1 mM) was added just before the cells were lysed by passing 
through a French Press cell at 15,000 psi three times, and the lysate was clarified by 
ultracentrifugation (40,000 rpm, 40 min).  Cleared lysate was subjected to heat denaturation at 
74° C for 14 min to precipitate thermolabile E. coli proteins which were then removed by 
ultracentrifugation (40,000 rpm, 40 min).  The supernatant was incubated with 8 ml IMAC 
Fastflow6 resin (Ni2+ charged, GE Healthcare) and rocked slowly for 3 hours in the presence of 
10 mM imidazole.  The supernatant was then removed by centrifugation in a swing bucket 
Table 6. DNA Primers for Sso PolB1 exonuclease deficient mutant 
D231A  
E233A 
Forward 5'-AAAAGGGTTGCGATAGCCATTGCGGTATATACACCAGTTAAG -3' 
Reverse 5'-AACTGGTGTATATACCGCAATGGCTATCGCAACCCTTTTTATTTTAG -3' 
D318A 
Forward 5'-CAATGGAGACGATTTTGCTTTACCTTACATTTAC -3' 
Reverse 5'-GTAAATGTAAGGTAAAGCAAAATCGTCTCCATTG -3' 
 
Newmister 27 
 
Fig. 14.  SDS PAGE gel showing the 
purification of PolB1 
centrifuge (2500 rpm, 2.5 min) and the resin was packed into a HR-10/10 FPLC column (GE 
Healthcare).  The PolB1 bound to the resin was purified through a linear gradient of 35–500 
mM imidazole in Buffer B (10 mM KHPO4, pH 7.0, 350 mM NaCl, 5–500 mM Imidazole, 10% 
Glycerol, 0.05% β-mercaptoethanol).  Fractions containing PolB1 were dialyzed for 3 hours 
against dialysis Buffer C (50 mM Tris-HCl, pH 7.5 at 25° C, 50 mM NaCl, 1 mM EDTA, 10% 
Glycerol, 0.1% β-mercaptoethanol).  The dialyzed protein solution was passed through two 5 
mL HiTrap Q anion exchange columns (GE Healthcare).  The loading elute was applied to two 
5 mL HiTrap SP cation exchange columns (GE Healthcare) and eluted using a gradient of 
100—1000 mM NaCl in buffer C.  The fractions containing PolB1 were dialyzed against buffer 
D (25 mM HEPES, pH 7.0 at 4° C, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 50% Glycerol) and 
stored at -80° C.  The concentrations of the purified PolB1 mutants were measured 
spectrophotometrically at 280 nm using the calculated extinction coefficient 124,785 M-1cm-1.   
 
Summary of Results 
The PolB1 D231A, E233A, D318A triple substitution 
mutant has been purified to apparent homogeneity (Fig. 
14), but no further studies have been done to date.  The 
enzyme will be tested for exonuclease activity by 
incubating the enzyme with a 5’ 32P-labeled DNA 
substrate in the presence of Mg2+.  A marked 
degradation pattern will be readily visible if the enzyme 
still possesses exonuclease activity. 
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